Author
Unnikrishnan is currently Senior Associate Editor with BW Businessworld at its Mumbai Bureau. During his two decades long journalistic career, he has received several media awards and recognitions. His articles on healthcare, life sciences and intellectual property rights (IPR) have been republished by several international blogs and journals.
The ONGC-HPCL merger appears to be a bad idea for the government and the industry
Read More
The biggest failure in India's public healthcare system has been the poor focus on providing primary healthcare
Read More
C H Unnikrishnan profiles Gursimran Kaur Mann, managing director of Simbhaoli Sugar
Read More
C H Unnikrishnan on how Isha Ambani is playing a big role in Reliance Jio
Read More
The profile of Nita Ambani, who debuted in the Forbes list of Asia’s most powerful businesswoman in 2015 at the top spot, is currently on the rise both inside Reliance empire and outside
Read More
The Agrawal brothers of Ajanta Pharma — Yogesh and Rajesh could achieve this 360 degree turn around of the family business, which was saddled with huge debt and declining growth, in the last 10 years
Read More
Tata Elxsi is looking at accelerating revenue from its existing operations to touch its Rs 3000 crore sales target in the next two years
Read More
In FY15-16, Torrent Pharma’s US business soared some 220 per cent compared to previous year, taking it to new heights
Read More
Alembic Pharma’s market value has jumped 14 times in four years. Credit goes to Pranav Amin for changing it into a more focused company
Read More
This acquisition will help KredX to enhance its technological capabilities on accounts receivables side along with the addition of the talent pool from Hummingbill
Read More
